ArticleThe Journal of international medical research2019

Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4.

Lu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.